Provided by Tiger Fintech (Singapore) Pte. Ltd.

iRadimed

58.45
+0.47000.81%
Post-market: 58.450.00000.00%19:09 EDT
Volume:100.52K
Turnover:5.83M
Market Cap:743.20M
PE:37.72
High:59.01
Open:58.02
Low:57.64
Close:57.98
Loading ...

IRadimed Corp. Up Over 13%, on Pace for Largest Percent Increase Since February 2022 -- Data Talk

Dow Jones
·
30 May

Lake Street Sticks to Their Buy Rating for Iradimed (IRMD)

TIPRANKS
·
29 May

IRadimed Corporation Receives FDA 510(k) Clearance for Next-Generation MRidium® 3870 Infusion Pump System

Reuters
·
29 May

IRadimed Corporation Announces FDA 510(K) Clearance for Mridium® 3870 Infusion Pump System

THOMSON REUTERS
·
29 May

IRadimed Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
05 May

IRadimed (IRMD) Lags Q1 Earnings Estimates

Zacks
·
05 May

iRadimed reports Q1 adjusted EPS 42c vs 36c last year

TIPRANKS
·
05 May

iRadimed sees Q2 EPS 41c-44c

TIPRANKS
·
05 May

IRadimed: Q1 Earnings Snapshot

Associated Press Finance
·
05 May

iRadimed Q1 Adj. EPS $0.42 Beats $0.41 Estimate, Sales $19.51M Beat $19.33M Estimate

Benzinga
·
05 May

BRIEF-IRadimed Q1 Revenue USD 19.5 Million

Reuters
·
05 May

IRadimed Corporation Announces First Quarter 2025 Financial Results

THOMSON REUTERS
·
05 May

IRadimed Corp - Expects Q2 2025 Revenue of $19.7M-$19.9M

THOMSON REUTERS
·
05 May

IRadimed Corp: Expects Q2 Adj EPS Between $0.41 to $0.44

THOMSON REUTERS
·
05 May

IRadimed Outlook Q2 Adjusted EPS USD 0.41-0.44

THOMSON REUTERS
·
05 May

IRadimed Outlook Q2 EPS USD 0.37-0.4

THOMSON REUTERS
·
05 May

IRadimed Q1 Adjusted EPS USD 0.42

THOMSON REUTERS
·
05 May

IRadimed Corp: Reaffirms FY 2025 Revenue and Earnings Guidance

THOMSON REUTERS
·
05 May

IRadimed Q1 Revenue USD 19.5 Million

THOMSON REUTERS
·
05 May

IRADIMED CORPORATION Announces First Quarter 2025 Financial Results

GlobeNewswire
·
05 May